Lipid peroxidation, nitrate and nitrite levels in eclamptic and intrauterine growth retarded pregnancies

Turkish Journal of Medical Sciences

Volumn 33, Issue 2, 2003, Pages 89-93

  Paşaoǧlu, Hatice ^a   Bukan, Neslihan ^a   Bulduk, Gülsen ^b   Çelen, Şevki ^c  

^a GAZI UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Research Hospital   (Turkey)

Author keywords

Eclampsia; IUGR; Lipid peroxidation; Nitric oxide

Indexed keywords

NITROGEN OXIDES; PATHOLOGY; PLASMAS;

PATHOGENESIS;

LIPIDS;

MALONALDEHYDE; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ECLAMPSIA; FEMALE; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; LIPID PEROXIDATION; METABOLITE; PATHOGENESIS;

EID: 0038587354     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cunningham FG, MacDonald PC, Gant NF et al. Hypertensive disorders of pregnancy. Williams' Obstetrics (Eds. Cunningham FG, MacDonald PC, Gant NF et al.) 19th ed. Norwalk, Connecticut: Appleton & Lange. 1993, pp: 763-817.
2. Goldenberg RL, Cutter GR, Hoffman HJ et al. Intrauterine growth retardation: Standards for diagnosis. Am J Obstet Gynecol 161: 271-277, 1989.
3. Bates JA, Evans JA, Mason G. Differentiation of growth retarded from normally grown fetuses and prediction of intrauterine growth retardation using Doppler ultrasound. Br J Obstet Gynecol 103: 670-675, 1996.
4. Singh S, Evans TW. Nitric oxide the biological mediator of the decade: Fact or fiction? Eur Respir J 10: 699-707, 1997.
5. Narin F, Narin N, Paşaoǧlu H et al. Nitric oxide level in children with pulmonary hypertension. Ind J Physiol Pharmacol 44: 335-339, 2000.
6. Sladek SM, Magness RR. Conrad KP, Nitric oxide and pregnancy. Am J Physiol 272: 441-463, 1997.
7. Seligman SP, Buyon JP, Clancy RM et al. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 171: 944-948, 1994.
8. Smarason AK, Allman KG, Young O et al. Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with preeclampsia. Br J Obstet Gynecol 104: 538-543, 1997.
9. Ranta V, Vionikka L, Halmesmaki E et al. Nitric oxide production with preeclampsia. Obstet & Gynecol 93: 442-445, 1999.
10. Davidge ST, Stranko CP, Roberts JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 174: 1008-1013. 1996.
11. Silver RK, Kupfermine MJ, Russell TL et al. Evaluation of nitric oxide as a mediator of severe preeclampsia. Am J Obstet Gynecol 175: 1013-1017, 1996.
12. Maseki M, Nishigaki I, Hagihara M et al. Lipid peroxide levels and lipid serum content of serum lipoprotein fractions of pregnant subjects with and without preeclampsia. Clin Chim Acta 155: 155-161, 1981.
13. McLaughlin MK: Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol 161: 1025-1034, 1989.
14. Curtis NE, Gudi NM, King RG et al. Nitric oxide metabolites in normal human pregnancy and preeclampsia. Hypertens Pregnancy 14: 339-349, 1995.
15. Hunter MIS, Nlemadim BC, Davidson DLW. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluids from multiple sclerosis patients. Neurochem Res 10: 1645-1652, 1985,
16. Wang Y, Walsh SW, Guo J et al. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 165: 1695-1700, 1991.
17. Pinto A, Sorrentino R, Sorrentino P et al. Endothelial-derived relaxing factor released by endothelial cells of human umblical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 164: 507-513, 1991.
18. Davidge ST, Billiar TR, Roberts JM. Plasma nitrites and nitrates, stable end products of nitric oxide, are elevated in women with preeclampsia. In: Proceedings of the ninth international congress of the International Society for the Study of Hypertension in Pregnancy. Sydney: Australia, March 15-18, 1994.
19. Norris LA, Higgins JR, Darling MRN et al. Nitric oxide in the uteroplacental, fetoplacental and peripheral circulations in preeclampsia. Obs & Gyn 93: 958-963, 1999.
20. Zeeman CG, Dekkar GA, Van Geijn HP et al. Endothelial function in normal and preeclamptic pregnancy: A hypothesis. Eur J Obstet Gynecol Reprod Biol 43: 113-122, 1992.
21. Creasy RK, Resnik R. Intrauterine growth restriction. Creasy & Resnik Maternal Fetal Medicine: Principles and practice (Eds. RK. Creasy, R. Resnik) W.B. Saunders Company. Philadelphia 1989, pp: 547-564.
22. Paternoster DM, Stella A, Mussap M et al. Predictive markers of preeclampsia in hypertensive disorders in pregnancy. Int J Gynecol Obstet 66: 232-243, 1999.
23. D'Ischia M, Palumbo A, Buzzo F. Interactions of nitric oxide with lipid peroxidation products under aerobic conditions: inhibitory effects on the formation of malondialdehyde and related thiobarbituric acid-reactive substances. Nitric Oxide: Biology and Chemistry 4: 4-14, 2000.
24. O'Donnell VB, Chumley PH, Hogg N et al. Nitric oxide inhibition of lipid peroxidation: Kinetics of reaction with lipid peroxyl radicals and comparison with a-tocopherol. Biochem 36: 15216-15523, 1997.
25. Van Buren GA, Yang D, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 167: 828-833, 1992.
26. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 169: 1316-1320, 1993.
27. Di Iorio R, Marinoni E, Coacci F et al. Amniotic fluid nitric oxide and uteroplacental blood flow in pregnancy complicated by intrauterine growth retardation. Br J Obstet Gynecol 104: 1134-1139, 1997.